Exploring the molecular mechanism of galectin-1 promotion of GC invasion and metastasis will provide new molecular markers for early diagnosis and prognostic evaluation for treating GC and improve the clinical diagnosis and treatment of GC peritoneal metastasis, which would be greatly important for improving patients’ survival rates. The gene discussed is LGALS1; the disease is gastric cancer.